David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$410M |
| 2 |
Chevron
CVX
|
+$400M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$381M |
| 4 |
Williams Companies
WMB
|
+$300M |
| 5 |
SLB Ltd
SLB
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$358M |
| 3 |
Biogen
BIIB
|
+$306M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$298M |
| 5 |
Bausch Health
BHC
|
+$298M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 11.89% |
| 2 | Technology | 10.04% |
| 3 | Healthcare | 9.38% |
| 4 | Consumer Discretionary | 8.99% |
| 5 | Industrials | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ODP
3351
DELISTED
ODP
ODP
| $328K | ﹤0.01% |
+3,782
| New | +$348K |
|
|
EARN
3352
Ellington Residential Mortgage REIT
EARN
$168M
| $327K | ﹤0.01% |
22,922
+10,752
| +88% | +$171K |
|
3353
SFL Corp
SFL
$1.63B
| $327K | ﹤0.01% |
+20,062
| New | +$321K |
|
|
AFOP
3354
DELISTED
Alliance Fiber Optic Prod Inc
AFOP
| $327K | ﹤0.01% |
+17,648
| New | +$339K |
|
|
ACOR
3355
DELISTED
Acorda Therapeutics
ACOR
| $326K | ﹤0.01% |
82
-122
| -60% | -$471K |
|
|
OMN
3356
DELISTED
OMNOVA Solutions Inc.
OMN
| $326K | ﹤0.01% |
43,560
-21,234
| -33% | -$168K |
|
|
MXPT
3357
DELISTED
MaxPoint Interactive, Inc.
MXPT
| $326K | ﹤0.01% |
+10,075
| New | +$342K |
|
3358
Sturm, Ruger & Co
RGR
$615M
| $325K | ﹤0.01% |
5,663
-48,359
| -90% | -$2.63M |
|
|
COBZ
3359
DELISTED
CoBiz Financial,Inc
COBZ
| $322K | ﹤0.01% |
24,669
+7,339
| +42% | +$90.1K |
|
|
ATRS
3360
DELISTED
Antares Pharma, Inc.
ATRS
| $319K | ﹤0.01% |
153,337
+18,828
| +14% | +$45.7K |
|
|
PSUN
3361
DELISTED
PACIFIC SUNWEAR OF CAL. INC
PSUN
| $319K | ﹤0.01% |
280,205
+2,311
| +0.8% | +$4.35K |
|
3362
Winmark
WINA
$1.26B
| $318K | ﹤0.01% |
3,226
-199
| -6% | -$18.5K |
|
3363
CALL
Chord Energy
CHRD
$7.91B
| $317K | ﹤0.01% |
20,000
-90,000
| -82% | -$1.52M |
|
|
ARO
3364
PUT
DELISTED
Aeropostale Inc
ARO
| $317K | ﹤0.01% |
195,900
-57,400
| -23% | -$151K |
|
|
BIOL
3365
DELISTED
Biolase, Inc.
BIOL
| $315K | ﹤0.01% |
15
+1
| +7% | +$24.4K |
|
|
USAK
3366
DELISTED
USA Truck Inc
USAK
| $315K | ﹤0.01% |
14,844
-1,956
| -12% | -$48.5K |
|
|
ZU
3367
DELISTED
ZULILY INC CLASS A COMMON STOCK
ZU
| $314K | ﹤0.01% |
24,110
+11,491
| +91% | +$156K |
|
|
CEL
3368
DELISTED
Cellcom Israel, Ltd.
CEL
| $313K | ﹤0.01% |
81,859
+11,194
| +16% | +$48.8K |
|
|
FMER
3369
DELISTED
FIRSTMERIT CORP
FMER
| $312K | ﹤0.01% |
+15,001
| New | +$298K |
|
3370
MasTec
MTZ
$20.5B
| $311K | ﹤0.01% |
15,650
-322,529
| -95% | -$6.03M |
|
|
SZYM
3371
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
| $311K | ﹤0.01% |
99,053
-129,896
| -57% | -$445K |
|
|
MOMO
3372
Hello Group
MOMO
$841M
| $310K | ﹤0.01% |
19,259
+83
| +0.4% | +$1.16K |
|
3373
Stoneridge
SRI
$205M
| $310K | ﹤0.01% |
26,462
-1,205
| -4% | -$14.5K |
|
|
AVNS
3374
CALL
DELISTED
Avanos Medical
AVNS
| $309K | ﹤0.01% |
7,620
| – | – |
|
3375
FNB Corp
FNB
$6.58B
| $309K | ﹤0.01% |
+21,547
| New | +$292K |
|
Similar funds
David Shaw's Q2 2015 Portfolio in Review
As of Q2 2015, David Shaw held 4,083 positions worth $67.1B, up 2.8% from $65.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw's Q2 2015 filing shows 504 new, 1,541 increased, 1,229 reduced and 364 closed positions. Its largest new stake was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $479M.
By sector, the portfolio is most concentrated in Energy at 12% of assets, up from 10% a quarter earlier, followed by Technology and Healthcare.
- David Shaw's largest Q2 2015 buy was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M.
- David Shaw added most to Gilead Sciences in Q2 2015, an estimated $410M increase.
- David Shaw's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $479M.
- David Shaw fully exited TRW AUTOMOTIVE HOLDINGS CORP in Q2 2015, selling an estimated $164M.
- David Shaw's ten largest holdings make up 11% of its $67.1B portfolio in Q2 2015.
- David Shaw opened 504 new positions and closed 364 in Q2 2015.
- David Shaw's portfolio value rose 2.8% quarter-over-quarter to $67.1B.
Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.